战略与国际研究中心-Iraqs-Past-and-Future-Biological-Weapons-Capabilities_26页_83kb

Summary of "Iraqis Past and Future Biological Weapons Capabilities"

Introduction

Iraq had a significant biological weapons program during the Gulf War, capable of producing large quantities of agents such as Botulinum toxin, Anthrax, and Aflatoxin. The program was initially based at Al Kindi and Salman Pak but was moved to Al-Hakam and other facilities before the war. Despite the lack of attention given to biological weapons compared to other WMDs, the program was considered highly effective, with potential to cause widespread casualties. The UN and its inspection body, UNSCOM, have been actively working to identify and destroy these capabilities since the war, but challenges remain due to the program's complexity and secrecy.

Core Content

• Biological Weapons Capabilities Before the Gulf War:
  Iraq had a well-developed program with multiple facilities and a range of agents, including Botulinum toxin, Anthrax, Aflatoxin, and Ricin.

  • The program was initiated in the 1970s and became more advanced in the mid-1980s.
  • Facilities such as Muthanna, Al-Hakam, Salman Pak, and Taji were involved in research and production.
  • Iraq had tested various agents on animals and conducted field trials to weaponize them.
  • The program was primarily aimed at Iran, but also had potential to deter Israeli nuclear attacks.

• Key Agents and Their Characteristics:

  • Botulinum Toxin: Extremely potent, 3 million times more powerful than Sarin. Could contaminate 3,700 square kilometers.
  • Anthrax: More persistent and could contaminate a larger area.
  • Aflatoxin: A naturally occurring carcinogen, weaponized in 1990.
  • Clostridium Perfringens: A gangrene-causing agent.
  • Ricin: A deadly protein toxin, with some evidence of continued research through 1997.
  • Mycotoxins: Including T-2 and DAS, used for testing.
  • Viruses: Research into 17 different viruses, including haemorrhagic conjunctivitis, rotavirus, and camel pox, was conducted at Salman Pak.

Main Points

• Production and Weaponization:

  • Iraq had a total of 19,000 liters of Botulinum toxin, 8,500 liters of Anthrax, and 2,220 liters of Aflatoxin in stock.
  • At least 10,000 liters of Botulinum toxin and 1,580 liters of Aflatoxin were weaponized.
  • The program included the use of Scud missiles, aerial bombs, and even drop tanks for aircraft and UAVs.

• Facilities and Equipment:

  • Iraq had 79 facilities under monitoring, with nine classified as Category A (high priority).
  • Al-Hakam was a key facility, with multiple fermenters for producing agents.
  • Iraq imported specialized equipment such as growth agents, fermenters, and spray dryers to support its biological weapons production.

• Challenges in Inspection:

  • UNSCOM faced difficulties in verifying Iraq's claims due to the lack of transparency and the destruction or concealment of evidence.
  • Some facilities, like Al-Hakam, were not targeted during the Gulf War, raising concerns about unaccounted production.
  • Iraq claimed to have destroyed its biological weapons, but evidence suggests otherwise.

Key Information

• Weaponization Efforts:

  • Iraq weaponized Botulinum toxin, Anthrax, and Aflatoxin using Scud warheads, aerial bombs, and artillery shells.
  • The program included the development of a 2,000-liter drop tank for aircraft and RPVs, though Iraq claimed the tests were a failure.
  • There are unconfirmed reports of remote-controlled Japanese crop spraying helicopters.

• Post-Gulf War Capabilities:

  • The exact status of Iraq's biological weapons stockpiles after the Gulf War remains uncertain.
  • Iraq admitted to producing biological agents, but the extent of its capabilities and whether any were retained is unclear.
  • Anthrax spores are highly resilient, but Iraq may have only deployed wet agents, which have limited shelf-life.

• UNSCOM and Iraq's Cooperation:

  • Iraq provided six versions of its FFCDs, but these were incomplete and lacked detailed information.
  • The discovery of the true scale of the program came after Hussein Kamel's defection in 1995.
  • UNSCOM was not allowed to collect soil samples or interview key personnel, making verification difficult.

Conclusion

Iraq's biological weapons program was extensive and well-developed before the Gulf War, with significant capabilities in production and weaponization. Despite efforts by the UN and its inspection teams, the program's true extent and current status remain uncertain due to lack of transparency and the possibility of retained agents. The program's potential for large-scale casualties and the difficulty in detecting and verifying biological weapons make it a persistent concern for international security.